Serum selenium concentrations in ovarian cancer patients using a simplified fluorimetric procedure

Serum selenium concentrations in ovarian cancer patients using a simplified fluorimetric procedure

10.1007/BF02795620

Saved in:

書目詳細資料
Main Authors:	Das, N.P., Ma, C.W., Salmon, Y.M.
其他作者:	BIOCHEMISTRY
格式:	Article
出版:	Humana Press 2013
主題:	antioxidant fluorimetric method, for determination of serum Se nutritional anticancer agent ovarian cancer Serum selenium, concentrations in ovarian cancer patients trace element carcinogenesis
在線閱讀:	http://scholarbank.nus.edu.sg/handle/10635/38037
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

RUNX3 functions as an oncogene in ovarian cancer
由: Lee, C.W.L., et al.
出版: (2014)

Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
由: Koh, S.C.L., et al.
出版: (2016)

EXPLOITING DNA DAMAGE RESPONSE PATHWAY: DEVELOPMENT OF PTK6 INHIBITOR FOR TREATMENT OF OVARIAN CANCER
由: ANG HUI LI
出版: (2021)

Identification of common oncogenic and early developmental pathways in the ovarian carcinomas controlling by distinct prognostically significant microRNA subsets
由: Kuznetsov, Vladimir A., et al.
出版: (2018)

TARGETING THE WNT PATHWAY IN OVARIAN CANCER DISSEMINATION
由: WONG MENG KANG
出版: (2015)

Overripening of ovulated eggs in goldfish, Carassius auratus: II. Possible involvement of postovulatory follicles and steroids
由: Formacion, M.J., et al.
出版: (2014)

Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer
由: Huang, R.Y.-J., et al.
出版: (2014)

Haemostatic status in patients with ovarian cancer compared with patients with benign ovarian cysts and the study of the relationships between haemostatic levels in ovarian cancer patients with known survival outcome
由: KOH CHEE LIANG, STEPHEN
出版: (2010)

The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer
由: Yamamura, S., et al.
出版: (2014)

Epithelial ovarian cancer
由: Ng, J.S., et al.
出版: (2016)

Ovarian Cancer
出版: (2017)

DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
由: SHAIKH MOHAMMED ISHAQUE
出版: (2012)

Activation of STAT3 and STAT5 signaling in epithelial ovarian cancer progression: Mechanism and therapeutic opportunity
由: Wu, C.-J., et al.
出版: (2021)

Ovarian cancer proteomics: Many technologies one goal
由: Narasimhan, K., et al.
出版: (2011)

SERS-based detection of haptoglobin in ovarian cyst fluid as a point-of-care diagnostic assay for epithelial ovarian cancer
由: Perumal, J., et al.
出版: (2022)

Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model
由: Feki, A., et al.
出版: (2011)

Use of hormone replacement therapy before and after ovarian cancer diagnosis, and ovarian cancer survival
由: Mascarenhas, C., et al.
出版: (2015)

Ovarian response after laparoscopic ovarian cystectomy for endometriotic cysts in 132 monitored cycles
由: Loh, F.-H., et al.
出版: (2013)

Genetic and epigenetic alterations in the BRCAI gene in Singapore breast and/or ovarian cancer: A population-based study
由: AZHAR BIN ALI
出版: (2010)

INVOLVEMENT OF BAD PHOSPHORYLATION IN THE RESPONSE OF OVARIAN CANCER TO CHEMOTHERAPEUTICS
由: WANG YANXIN
出版: (2020)

Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft
由: Chaudhury, A., et al.
出版: (2014)

Serum Tumor Markers in Gynecologic Cancers
由: ชื่นกมล ชรากร, et al.
出版: (2022)

FOLATE RECEPTOR TARGETED LIPOSOMES AS THE ENABLING TECHNOLOGY FOR THE DELIVERY OF CHEMOTHERAPEUTICS IN THE TREATMENT OF OVARIAN CANCER
由: ANUMITA CHAUDHURY
出版: (2012)

Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft
由: Shaikh, I.M., et al.
出版: (2014)

SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway
由: Zhu, W., et al.
出版: (2021)

The association between fibrinogen, von Willebrand Factor, antithrombin III, and D-dimer levels and survival outcome by 36 months from ovarian cancer
由: Koh, S.C.L., et al.
出版: (2011)

First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient
由: Prasath, E.B., et al.
出版: (2016)

Proteomics-based identification of potential protein biomarkers for epithelial ovarian cancer
由: ZHAO CHANGQING
出版: (2010)

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
由: Lu, Yen-Shen, et al.
出版: (2022)

Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As 2O 3 and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR
由: Ong, P.-S., et al.
出版: (2014)

Serum zinc, copper, and chromium concentration in normal subjects and surgical patients with cancer in Siriraj Hospital
由: Nualnit Wichien, 1973-
出版: (2007)

Application of porous membrane protected micro-solid-phase-extraction combined with gas chromatography-mass spectrometry for the determination of estrogens in ovarian cyst fluid samples
由: Kanimozhi, S., et al.
出版: (2014)

Preclinical activity of embryonic annexin A2-specific chimeric antigen receptor T cells against ovarian cancer
由: Leong, L., et al.
出版: (2021)

Effects of maternal selenium-supplementation at varying stages of periconception period on murine blasctocyst morphology and implantation status
由: Mamon, Mark Anthony C.
出版: (2015)

Responses of polycystic ovarian syndrome and related variants to low-dose follicle stimulating hormone
由: Yong, E.L., et al.
出版: (2016)

Multiple signatures of a disease in potential biomarker space : getting the signatures consensus and identification of novel biomarkers
由: Ow, Ghim Siong, et al.
出版: (2018)

Identification and validation of cancerous targets of kusunokinin
由: Tanotnon Tanawattanasuntorn
出版: (2023)

An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
由: Huang, R.Y.-J., et al.
出版: (2014)

Malignant ovarian germ-cell tumours
由: Low, J.J.H., et al.
出版: (2016)

Potential of tyrosine kinase receptor TIE-1 as novel therapeutic target in high-PI3K-expressing ovarian cancer
由: Zhang, X., et al.
出版: (2021)